EBOS Group Ltd
NZX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
NZX:EBO
Watchlist
Price: 38.4 NZD -0.26% Market Closed
Market Cap: 7.5B NZD
Have any thoughts about
EBOS Group Ltd?
Write Note

Net Margin
EBOS Group Ltd

2.1%
Current
2%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.1%
=
Net Income
271.5m
/
Revenue
13.2B

Net Margin Across Competitors

Country NZ
Market Cap 7.4B NZD
Net Margin
2%
Country US
Market Cap 78.5B USD
Net Margin
1%
Country US
Market Cap 48.7B USD
Net Margin
1%
Country US
Market Cap 48.7B USD
Net Margin
1%
Country US
Market Cap 29.8B USD
Net Margin
1%
Country US
Market Cap 9.4B USD
Net Margin
3%
Country CN
Market Cap 65.3B CNY
Net Margin
8%
Country KR
Market Cap 12.2T KRW
Net Margin
7%
Country CN
Market Cap 60.9B CNY
Net Margin
1%
Country CN
Market Cap 64.9B HKD
Net Margin
1%
Country IT
Market Cap 5.5B EUR
Net Margin
7%
No Stocks Found

EBOS Group Ltd
Glance View

Market Cap
7.4B NZD
Industry
Health Care

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.

EBO Intrinsic Value
56.1 NZD
Undervaluation 32%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.1%
=
Net Income
271.5m
/
Revenue
13.2B
What is the Net Margin of EBOS Group Ltd?

Based on EBOS Group Ltd's most recent financial statements, the company has Net Margin of 2.1%.